A Bile Acid Derivative Could Help Restore the Maturation of Aging Eggs
A compound best known for protecting cells from stress has shown a striking ability to improve the maturation of aging eggs in laboratory experiments, raising hopes for more effective assisted-reproduction treatments for women of advanced maternal age. Tauroursodeoxycholic acid, or TUDCA, helped older mouse and human oocytes progress through a critical stage of development while reducing cellular damage linked to aging, according to research published in BMC Biology. The study suggests that the compound works by calming a molecular emergency system inside the oocyte called the unfolded protein response. In particular, TUDCA dampened the activity of a stress pathway involving the proteins PERK, eIF2α and CHOP. The treatment also improved mitochondrial function, reduced the accumulation of reactive oxygen species and lowered the frequency of abnormal chromosome-spindle structures. The findings remain experimental: the oocytes were matured outside the body, and the work does not establish that TUDCA can improve pregnancy or birth rates in patients. But it identifies a potential way to address one of the central biological problems of reproductive aging before it compromises embryo development.
Human fertility declines with age largely because the number and quality of available oocytes decrease over time. Oocytes are unusually vulnerable to aging because they must preserve their molecular integrity for years, sometimes decades, before completing maturation and participating in fertilization. During in vitro maturation, or IVM, an immature oocyte collected at the germinal-vesicle stage is cultured until it reaches metaphase II, the stage at which it can normally be fertilized. This process is especially difficult for older oocytes. Their internal structures are more prone to deterioration, their mitochondria may produce energy less efficiently and their chromosome-segregation machinery is more likely to malfunction. These defects can lead to failed maturation, abnormal embryos or developmental arrest. The researchers at Tongji Hospital and Huazhong University of Science and Technology investigated whether endoplasmic reticulum stress might be a previously underappreciated driver of this decline. The endoplasmic reticulum is the cell’s protein-folding and processing network. When misfolded proteins accumulate, the organelle activates a protective response designed to restore balance. In aging oocytes, however, prolonged or excessive activation can become damaging rather than protective.
The team compared germinal-vesicle-stage oocytes from 45-week-old mice with those from 6-week-old mice, using IVM to observe how aging altered the cells during maturation. They also examined human oocytes donated by women aged 38 or older and compared them with oocytes from women aged 30 or younger. To identify molecular differences that might explain the reduced performance of aged cells, the investigators used microproteomic analysis, a highly sensitive method capable of measuring changes in many proteins from extremely small biological samples. The analysis indicated that older oocytes experienced substantially greater endoplasmic reticulum stress during IVM. This stress was accompanied by increased reactive oxygen species, chemically reactive molecules that can damage proteins, lipids and DNA when antioxidant defenses are overwhelmed. The aged oocytes also showed signs of mitochondrial dysfunction. Because mitochondria generate adenosine triphosphate, the energy currency required for chromosome movement, spindle assembly and other maturation events, their impairment could create a damaging feedback loop: stressed cells generate more oxidative molecules, while damaged mitochondria become less able to meet the cell’s energy demands.
TUDCA is a taurine-conjugated form of ursodeoxycholic acid, a bile acid derivative with chemical properties that allow it to act as a molecular chaperone. Rather than functioning as a conventional antioxidant alone, TUDCA is thought to assist protein-folding systems and reduce the burden of unfolded or misfolded proteins in the endoplasmic reticulum. In the experiments, the researchers added TUDCA at a concentration of 100 micromolar to the maturation cultures of aged oocytes. The treatment attenuated molecular markers of endoplasmic reticulum stress and suppressed the downstream PERK-eIF2α-CHOP signaling cascade. This pathway is one branch of the integrated stress response. Under stressful conditions, PERK phosphorylates eIF2α, a translation-control factor, reducing the production of newly synthesized proteins and thereby easing pressure on the endoplasmic reticulum. If the stress persists, the pathway increases the activity of CHOP, a transcription factor associated with cellular dysfunction and apoptosis. TUDCA appeared to prevent this protective response from remaining chronically activated, helping aged oocytes proceed through maturation instead of entering a state of metabolic and structural decline.
The functional consequences were visible in the oocytes’ behavior. TUDCA significantly increased the rate at which aged oocytes extruded their first polar body, a small cellular compartment released during the asymmetric division that accompanies meiotic maturation. First polar body extrusion is a widely used indicator that an oocyte has reached the appropriate stage for fertilization. The treatment also reduced defects in the meiotic spindle, the microtubule-based structure that organizes and separates chromosomes. Spindle abnormalities are particularly important in reproductive aging because they can cause chromosomes to be distributed unevenly between the mature oocyte and the polar body. Such errors may produce aneuploid embryos, in which cells carry an abnormal number of chromosomes. Although the study did not claim to eliminate these risks, the reduction in spindle abnormalities suggests that relieving endoplasmic reticulum stress may stabilize the broader network of organelles and cytoskeletal structures required for accurate meiosis. The result connects a biochemical stress pathway to one of the most visible physical defects in aging oocytes.
The researchers also found evidence that TUDCA restored aspects of mitochondrial health. Treated oocytes showed improved mitochondrial membrane potential, an electrical gradient across the inner mitochondrial membrane that reflects the organelle’s ability to produce ATP. They also accumulated fewer reactive oxygen species during IVM. Mitochondria and the endoplasmic reticulum are not isolated compartments; they communicate at specialized contact sites known as mitochondria-associated endoplasmic reticulum membranes. These junctions help regulate calcium transfer, lipid metabolism and energy production, but they can also transmit stress. Excessive calcium movement from the endoplasmic reticulum into mitochondria can disrupt respiration and promote the generation of reactive oxygen species. By reducing endoplasmic reticulum stress, TUDCA may have interrupted this damaging exchange, although the precise contribution of these contact sites was not fully established by the study. The findings nonetheless support a model in which protein-folding stress, oxidative damage and energy failure reinforce one another during oocyte aging.
The study went beyond measurements made immediately after maturation by examining what happened after fertilization. Oocytes exposed to TUDCA during IVM displayed improved developmental potential in subsequent embryo culture experiments. In other words, the treatment did not merely make the cells appear more mature under the microscope; it was associated with a greater capacity to support early embryonic development. Early embryos rely heavily on maternal proteins, messenger RNAs and mitochondria stored in the oocyte, so the quality of the mature egg can influence development before the embryo’s own genome becomes fully active. The researchers assessed developmental outcomes using laboratory embryo culture and markers of early embryonic quality, including factors associated with the inner cell mass and pluripotency. These observations provide a more meaningful test than polar body extrusion alone, but they still represent preclinical evidence. Embryo development in a dish does not predict implantation, healthy pregnancy or the long-term health of offspring, and the study did not demonstrate those outcomes.
Experiments with human oocytes produced a similar overall pattern. Oocytes from women of advanced maternal age showed stronger signs of endoplasmic reticulum stress during IVM, while TUDCA treatment improved maturation and alleviated those stress signals. The human findings are important because animal oocytes can differ from human oocytes in their timing of maturation, metabolic requirements and response to culture conditions. Yet the human component was still limited to laboratory maturation rather than a clinical trial. The oocytes were handled under approved ethics procedures, and participants provided informed consent, but the study did not test TUDCA in patients undergoing in vitro fertilization. Questions remain about the safest dose, the optimal timing of exposure, whether the compound affects epigenetic programming and whether any benefits persist through implantation and fetal development. It is also unclear whether TUDCA would help all patients with diminished ovarian reserve or only those whose oocytes exhibit a particular form of stress-related dysfunction.
The findings point toward a possible refinement of assisted reproductive technology rather than an age-reversing fertility drug. IVM is being explored as a way to mature immature oocytes in the laboratory, potentially reducing the need for intensive hormonal stimulation in some treatment settings and offering a strategy for patients whose eggs are difficult to mature. Culture conditions, however, can impose their own stresses, and aged oocytes may be less able to withstand them. A compound that moderates the endoplasmic reticulum’s stress response could therefore become part of a carefully optimized culture system. Before that possibility can be considered clinically, researchers will need to reproduce the results in larger collections of human oocytes, define the molecular targets of TUDCA more precisely and establish whether improved maturation corresponds to euploid embryos and healthy live births. The new work is significant because it identifies the PERK-eIF2α-CHOP axis as a potentially actionable link between aging, organelle stress and meiotic failure. It also illustrates how protecting the cell’s protein-handling machinery may help preserve the delicate energy and chromosome systems that determine whether an aging oocyte can successfully begin a new life.
Subject of Research: Tauroursodeoxycholic acid treatment for improving in vitro maturation of aged mouse and human oocytes
Article Title: Tauroursodeoxycholic acid rescues aged oocyte maturation in vitro by alleviating ER stress-induced PERK-eIF2α-CHOP activation
Article References: Liu, W., Yu, Q., Zhang, C. et al. “Tauroursodeoxycholic acid rescues aged oocyte maturation in vitro by alleviating ER stress-induced PERK-eIF2α-CHOP activation.” BMC Biology (2026). Original research article
Image Credits: AI Generated
DOI: 10.1186/s12915-026-02723-3
Keywords: oocyte aging, in vitro maturation, tauroursodeoxycholic acid, endoplasmic reticulum stress, PERK-eIF2α-CHOP pathway, mitochondrial function, reactive oxygen species, assisted reproductive technology
Tags: aging-related decline in female fertilityassisted reproductive technology advancementscellular damage mitigation in reproductive agingchromosome-spindle structure stabilityER stress and unfolded protein response in oocytesexperimental effects of TUDCA on human and mouse oocyteslaboratory studies on oocyte developmentmitochondrial function improvement in aged eggspotential fertility treatments for older womenreactive oxygen species reduction in reproductive cellsreproductive aging and cellular stress reductionTUDCA in vitro egg maturation
